BIOTECH REGULATIONS:
Paving the Way for British Xenotransplants
Nigel Williams
The transplantation of animal organs into humans moved a step closer in Britain last week, when the government circulated to hospitals a set of national guidelines intended to ensure that proposed clinical trials don't put patients or the public at risk of new diseases. The proposed trials remain highly controversial, but by providing a regulatory framework, the new rules encourage companies to move ahead, say officials at Imutran, a Cambridge-based company working toward eventual xenotransplantation trials.